Dynavax Technologies (DVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,793 | -3,509 | 5,070 | -15,971 | -10,808 |
| Depreciation Amortization | 1,428 | 1,027 | 502 | 897 | 387 |
| Accounts receivable | 2,070 | 2,387 | -5,826 | -2,911 | -3,324 |
| Accounts payable and accrued liabilities | 868 | 229 | -662 | -19 | 649 |
| Other Working Capital | -4,943 | -4,908 | -13,938 | 5,024 | 6,461 |
| Other Operating Activity | -1,993 | -1,975 | 6,798 | 5,648 | 4,608 |
| Operating Cash Flow | $-14,363 | $-6,749 | $-8,056 | $-7,332 | $-2,027 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 16,849 | -4,522 | 2,854 | -44,088 | 5,549 |
| PPE Investments | -452 | -363 | -81 | -1,863 | -1,654 |
| Investing Cash Flow | $16,397 | $-4,885 | $2,773 | $-45,951 | $3,895 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | 427 | 92 | 32 | 272 | 52 |
| Common Stock Issued | 121 | 72 | 66 | 46,541 | 46,534 |
| Other Financing Activity | 0 | 0 | 0 | -408 | -408 |
| Financing Cash Flow | $548 | $164 | $98 | $46,405 | $46,178 |
| Exchange Rate Effect | -4 | -4 | -4 | N/A | N/A |
| Beginning Cash Position | 16,590 | 16,590 | 16,590 | 23,468 | 23,468 |
| End Cash Position | 19,168 | 5,116 | 11,401 | 16,590 | 71,514 |
| Net Cash Flow | $2,578 | $-11,474 | $-5,189 | $-6,878 | $48,046 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,363 | -6,749 | -8,056 | -7,332 | -2,027 |
| Capital Expenditure | -452 | N/A | -81 | -1,863 | -1,654 |
| Free Cash Flow | -14,815 | -6,749 | -8,137 | -9,195 | -3,681 |